0 Commentarios
0 Acciones
539 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
-
Noticias Feed
- EXPLORE
-
Páginas
-
Grupos
-
Eventos
-
Blogs
-
Marketplace
-
Foros
-
Please log in to like, share and comment!
-
Are Personalized Cancer Vaccines the Future of Oncology Treatment?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value Data Bridge Market Research analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030. The market...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Best Doctors for Stomach Cancer Treatment in IndiaAre you someone looking for the right doctor for stomach cancer treatment in India? When you are dealing with something serious, you need the best cancer specialist in India. So many hospitals, specialists, and treatment options are available, especially for international patients. However, people naturally wonder: Who are the best cancer doctors in India I can...0 Commentarios 0 Acciones 4K Views 0 Vista previa
-
Best Doctors for Stomach Cancer Treatment in IndiaAre you someone looking for the right doctor for stomach cancer treatment in India? When you are dealing with something serious, you need the best cancer specialist in India. So many hospitals, specialists, and treatment options are available, especially for international patients. However, people naturally wonder: Who are the best cancer doctors in India I can...0 Commentarios 0 Acciones 4K Views 0 Vista previa
-
Can Immune-Modulating Biologic Drugs Redefine Cancer Treatment Worldwide?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Market Size and Share Analysis Report CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period This Immune-Modulating...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Commentarios 0 Acciones 171 Views 0 Vista previa
-
Colorectal Cancer Treatment Market Expands Globally with Innovations in Targeted Therapies"Executive Summary Colorectal Cancer Treatment Market : CAGR Value The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. This Colorectal Cancer Treatment Market report is structured with the thorough market analysis...0 Commentarios 0 Acciones 3K Views 0 Vista previa
-
Is Nanomedicine Revolutionizing Drug Delivery and Cancer Treatment at a Global Scale?Executive Summary Nanomedicine Market: Growth Trends and Share Breakdown The global nanomedicine market size was valued at USD 479.30 million in 2024 and is expected to reach USD 1,247.40 million by 2032, at a CAGR of 12.70% during the forecast period Nanomedicine Market research report is a verified source of data and information that provides a...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Is the Global Colorectal Cancer Treatment Market Advancing with Breakthrough Oncology Therapies?Executive Summary Colorectal Cancer Treatment Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Market drivers and market restraints...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Metastatic Castrate Resistant Prostate Cancer Treatment Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Metastatic Castrate Resistant Prostate Cancer Treatment Market : The global metastatic castrate resistant prostate cancer treatment market size was valued at USD 11.99 billion in 2024 and is expected to reach USD 22.37 billion by 2032, at a CAGR of 8.10% during the forecast period This Metastatic Castrate Resistant Prostate Cancer...0 Commentarios 0 Acciones 3K Views 0 Vista previa
-
Metastatic Castrate Resistant Prostate Cancer Treatment Market Leaders: Growth, Share, Value, Size, and Scope"Comprehensive Outlook on Executive Summary Metastatic Castrate Resistant Prostate Cancer Treatment Market Size and Share The global metastatic castrate resistant prostate cancer treatment market size was valued at USD 11.99 billion in 2024 and is expected to reach USD 22.37 billion by 2032, at a CAGR of 8.10% during the forecast period The insights...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Reviluamide Tablets: A Precision-Targeted New Option for Prostate Cancer TreatmentProstate cancer is one of the most common malignant tumors of the male reproductive system. Among them, metastatic hormone-sensitive prostate cancer (mHSPC) is characterized by rapid disease progression and high treatment complexity, making it a long-standing focus and challenge in clinical practice. As a novel androgen receptor inhibitor independently developed in China, Reviluamide Tablets (...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Are Advanced Therapies Improving Treatment Outcomes for Actinic Keratosis?Executive Summary Actinic Keratosis Treatment Market Market Size and Share Across Top Segments CAGR Value The global actinic keratosis treatment market size was valued at USD 3.36 billion in 2025 and is expected to reach USD 9.02 billion by 2033, at a CAGR of 13.14% during the forecast period Market drivers and market restraints covered in this...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...0 Commentarios 0 Acciones 250 Views 0 Vista previa
-
Are Immune-Modulating Biologics Redefining the Future of Cancer Immunotherapy?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Size and Share: Global Industry Snapshot CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period The research and analysis...0 Commentarios 0 Acciones 251 Views 0 Vista previa
-
Are Neoantigen Cancer Vaccines the Next Breakthrough in Personalized Oncology?Executive Summary Neoantigen Cancer Vaccine Therapy Market Market Size and Share Forecast CAGR Value The global neoantigen cancer vaccine therapy market size was valued at USD 986 Million in 2025 and is expected to reach USD 6547.71 Million by 2033, at a CAGR of 26.70% during the forecast period The comprehensive market information and data of...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Commentarios 0 Acciones 783 Views 0 Vista previa
-
CAR-T Cell Therapy Market Demand Rising Across Global HealthcareExpanding healthcare infrastructure in emerging economies is creating new opportunities for the CAR-T cell therapy market. Countries in Asia-Pacific and Latin America are investing in advanced cancer treatment facilities. This expansion supports global market growth. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR The global CAR-T Cell Therapy Market is witnessing...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Commentarios 0 Acciones 650 Views 0 Vista previa
-
Could Neoantigen Cancer Vaccines Be the Next Breakthrough in Personalized Oncology?Regional Overview of Executive Summary Neoantigen Cancer Vaccine Therapy Market by Size and Share CAGR Value The global neoantigen cancer vaccine therapy market size was valued at USD 986 Million in 2025 and is expected to reach USD 6547.71 Million by 2033, at a CAGR of 26.70% during the forecast period The strategies encompassed in the...0 Commentarios 0 Acciones 198 Views 0 Vista previa
Resultados de la búsqueda
Patrocinados
Patrocinados
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek